Resmonics combines deep learning & respiratory medicine research to offer the 1st CE-certified early-warning system of its kind that helps patients with chronic respiratory diseases manage their condition.
Resmonics has raised €137k across 1 funding round from 1 investor, most recently a round in Jun 2021. Based in Zurich, Switzerland; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-06-24 | Other | €137k |
| Venture Kick |
| View deal → |
